October 31, 2023
2 min read
Key takeaways:
- Dietary changes or physical activity implementation improves menstrual regulation, glycemia and fertility.
- Women with PCOS also experience a higher risk for obstructive sleep apnea and insomnia.
DENVER — For women with polycystic ovary syndrome, therapeutic lifestyle modifications help to regulate menstruation, improve glucose metabolism and increase fertility, according to a speaker at the Lifestyle Medicine Conference.
PCOS is the most common and treatable cause of infertility, but 70% of cases go undiagnosed, according to Mahima Gulati, MD, FACE, DipABLM, FACLM, associate professor of endocrinology at Quinnipiac University in Hamden, Connecticut. PCOS is diagnosed by the presence of two of the following:
- signs or symptoms of high androgens;
- irregular or absent menses; and
- polycystic ovaries identified via ultrasound.
Gulati noted that therapeutic lifestyle modifications are the cornerstone of PCOS management. In her experience, women with PCOS taking metformin 1,000 mg twice daily who also implemented therapeutic lifestyle changes — such as substantially reducing consumption of ultra-processed foods and exercising at least 30 minutes daily — experienced regulated menstrual periods, glycemic improvements, normalized serum testosterone levels and lipid parameters, improved skin health and spontaneous conception without the need for IVF.
“If I give somebody a drug, and I intend to give it only to regularize their period, but their liver gets better, their skin gets better and their lipids get better, we call it a PCOS trophic effect,” Gulati said during the presentation. “They are affecting other target organs other than just what I intended. So, this is kind of a pills for all ills.”
International evidence-based PCOS guidelines recommend weight and lifestyle management, including diet, physical activity and behavior, as first-line therapies for managing PCOS. In a meta-analysis published in The Journal of Clinical Endocrinology & Metabolism, researchers assessed different diets, such as Dietary Approaches to Stop Hypertension (DASH), Mediterranean and calorie restriction, for managing PCOS and found that dietary therapy improves various parameters, including BMI, body weight and waist circumference. These improvements were also observed in a meta-analysis comparing diet with metformin therapy.
A 2023 review published in BMC Endocrine Disorders looked at studies of different modalities of physical activity, aerobic, resistance and combinations of high-intensity interval training and observed improvement in BMI, body fat percentage, waist circumference and total cholesterol.
In addition, Gulati highlighted a study from 2018 that evaluated studies of sleep disturbances and PCOS and found that women with PCOS had a higher risk for obstructive sleep apnea vs. women without PCOS. According to Gulati, elevated energy levels can lead to obstructive sleep apnea, which also elevates the risk for insomnia due to women with PCOS having disrupted rhythm or melatonin secretion. Disrupted sleep also worsens PCOS, Gulati noted: If a woman is chronically sleep deprived then she will experience more inflammation and insulin resistance.
Gulati also highlighted how smoking increases the risk for metabolic syndrome, high blood pressure, increased fasting insulin and increased testosterone levels compared with not smoking.
“Tobacco is such a big oxidative stress for the body. So, no wonder all these cardiometabolic parameters in women with PCOS reverse with tobacco [cessation],” Gulati said. “We need to consider [advising] PCOS patients to quit smoking because that aggravates their cardiometabolic risk.”
In addition, alcohol consumption of less than one drink weekly among women with PCOS is independently associated with histologic nonalcoholic steatohepatitis. Finally, in vitro and animal studies demonstrated that marijuana, cocaine and opioid use all may disrupt ovulatory function, fertility and menstruation, Gulati said.
References:
Sources/Disclosures
Collapse
Gulati M. Lifestyle medicine’s role in common hormonal disorders. Presented at: LM2023 Lifestyle Medicine Conference; Oct. 29-Nov. 1, 2023; Denver (hybrid meeting).
Disclosures:
Gulati reports no relevant financial disclosures.